JP2002517249A5 - - Google Patents

Download PDF

Info

Publication number
JP2002517249A5
JP2002517249A5 JP2000553593A JP2000553593A JP2002517249A5 JP 2002517249 A5 JP2002517249 A5 JP 2002517249A5 JP 2000553593 A JP2000553593 A JP 2000553593A JP 2000553593 A JP2000553593 A JP 2000553593A JP 2002517249 A5 JP2002517249 A5 JP 2002517249A5
Authority
JP
Japan
Prior art keywords
ebv
use according
epitope
sequence
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000553593A
Other languages
English (en)
Japanese (ja)
Other versions
JP5138844B2 (ja
JP2002517249A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/013113 external-priority patent/WO1999064603A2/en
Publication of JP2002517249A publication Critical patent/JP2002517249A/ja
Publication of JP2002517249A5 publication Critical patent/JP2002517249A5/ja
Application granted granted Critical
Publication of JP5138844B2 publication Critical patent/JP5138844B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000553593A 1998-06-12 1999-06-10 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強 Expired - Fee Related JP5138844B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8915898P 1998-06-12 1998-06-12
US60/089,158 1998-06-12
PCT/US1999/013113 WO1999064603A2 (en) 1998-06-12 1999-06-10 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012116568A Division JP2012214477A (ja) 1998-06-12 2012-05-22 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強

Publications (3)

Publication Number Publication Date
JP2002517249A JP2002517249A (ja) 2002-06-18
JP2002517249A5 true JP2002517249A5 (cg-RX-API-DMAC7.html) 2006-07-13
JP5138844B2 JP5138844B2 (ja) 2013-02-06

Family

ID=22216014

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000553593A Expired - Fee Related JP5138844B2 (ja) 1998-06-12 1999-06-10 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強
JP2012116568A Pending JP2012214477A (ja) 1998-06-12 2012-05-22 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012116568A Pending JP2012214477A (ja) 1998-06-12 2012-05-22 抗原およびEBVGp350/220の受容体の同時刺激によるB細胞活性化および免疫グロブリン分泌の増強

Country Status (6)

Country Link
US (1) US6432679B1 (cg-RX-API-DMAC7.html)
EP (1) EP1086231A2 (cg-RX-API-DMAC7.html)
JP (2) JP5138844B2 (cg-RX-API-DMAC7.html)
AU (1) AU762799B2 (cg-RX-API-DMAC7.html)
CA (1) CA2331258C (cg-RX-API-DMAC7.html)
WO (1) WO1999064603A2 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248334B1 (en) * 1997-01-08 2001-06-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
AU762799B2 (en) * 1998-06-12 2003-07-03 Henry M. Jackson Foundation For The Advancement Of Military Medicine Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220
FR2819724B1 (fr) * 2001-01-22 2005-05-13 Inst Necker Moyens pour induire une reponse immune aux antigenes bacteriens polysccharidiques et aux structures proteiques des capsides de virus
US6820011B2 (en) * 2001-04-11 2004-11-16 The Regents Of The University Of Colorado Three-dimensional structure of complement receptor type 2 and uses thereof
GB0210682D0 (en) * 2002-05-09 2002-06-19 Glaxosmithkline Biolog Sa Novel use
EP1539811A4 (en) * 2002-09-16 2006-05-24 Elusys Therapeutics Inc PREPARATION OF BISPEQIFIC MOLECULES WITH POLYETHYLENE GLYCOL LINKER
CN100594037C (zh) 2002-11-15 2010-03-17 Musc研究发展基金会 通过补体受体2定向的补体调节剂
EP1599170B1 (en) * 2003-02-21 2013-01-16 Hasumi Llc (Dba Shukokai International) Human lymphocyte vaccine adjuvant
CA2556169C (en) * 2004-01-29 2011-11-22 Andrew Lees Use of amino-oxy functional groups in the preparation of vaccines
AU2006329215A1 (en) * 2005-12-22 2007-06-28 Conjuchem Biotechnologies Inc. Process for the production of preformed conjugates of albumin and a therapeutic agent
JP5250548B2 (ja) * 2006-06-21 2013-07-31 エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント 疾患の治療のための補体h因子の標的化
AU2010268367B2 (en) 2009-07-02 2016-10-20 Ith Immune Therapy Holdings Ab Exosome based treatment of cancer
JP5871798B2 (ja) 2009-07-02 2016-03-01 エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント 肝再生を刺激する方法
WO2011017101A2 (en) 2009-07-27 2011-02-10 Fina Biosolutions, Llc Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
CN102958535A (zh) 2009-11-05 2013-03-06 亚力史剑桥公司 阵发性夜间血红蛋白尿、溶血性贫血和涉及血管内和血管外溶血的疾病状态的治疗
BR122022002139B1 (pt) 2009-12-17 2022-08-23 Fina Biosolutions, Llc Processo de conjugação de carboidratos na preparação de vacinas conjugadas e suas respectivas vacinas
ES2743156T3 (es) 2010-04-23 2020-02-18 Serum Institute Of India Pvt Ltd Método simple para eliminación simultánea de múltiples impurezas a partir de sobrenadantes de cultivo a niveles ultrabajos
MX2012013233A (es) 2010-05-14 2013-05-20 Univ Colorado Regents Grupos que apuntan a receptor 2 de complemento (cr2) mejorados.
BR112012033119A2 (pt) 2010-06-22 2016-10-25 Univ Colorado Regents anticorpos para o fragamento c3d do componente do complemento 3.
EP2877205A4 (en) * 2012-07-26 2016-04-06 Jackson H M Found Military Med VACCINE WITH A MULTIMED FUSION PROTEIN AND IMMUNOTHERAPY
JP2015535212A (ja) 2012-08-17 2015-12-10 ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト 補体活性化を検出するための組成物および方法
US10413620B2 (en) 2012-08-17 2019-09-17 The Regents Of The University Of Colorado, A Body Corporate Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US5011912A (en) 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
AU4341189A (en) * 1988-10-03 1990-05-01 Scripps Clinic And Research Foundation The receptor binding region of ebvgp350
US5280113A (en) 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5310729A (en) 1990-04-20 1994-05-10 California Institute Of Biological Research Interferon-related polypeptides as CR2 ligands and their use for modulating immune cell functions
US5331090A (en) 1989-09-08 1994-07-19 California Institute Of Biological Research CR2 ligand compositions and methods for modulating immune cell functions
EP0625910B1 (en) 1992-02-11 2003-07-23 Henry M. Jackson Foundation For The Advancement Of Military Medicine Dual carrier immunogenic construct
WO1993019092A1 (fr) * 1992-03-19 1993-09-30 Centre National De La Recherche Scientifique Adenovirus recombinants defectifs exprimant des proteines caracteristiques du virus epstein-barr
US5521066A (en) 1993-09-13 1996-05-28 Bristol-Myers Squibb Company Periplasmic membrane-bound system for detecting protein-protein interactions
EP0720485B1 (en) 1993-09-22 2003-11-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
MY114769A (en) 1994-04-18 2003-01-31 Aviron Inc Non-splicing variants of gp350/220
GB9424631D0 (en) 1994-12-06 1995-01-25 Lynxvale Ltd Modulating the immune response
US5712149A (en) 1995-02-03 1998-01-27 Cell Genesys, Inc. Chimeric receptor molecules for delivery of co-stimulatory signals
DE69628418T2 (de) * 1995-03-22 2004-04-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
AU762799B2 (en) * 1998-06-12 2003-07-03 Henry M. Jackson Foundation For The Advancement Of Military Medicine Enhancement of B cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and EBV Gp350/220

Similar Documents

Publication Publication Date Title
Virelizier et al. Antibody responses to antigenic determinants of influenza virus hemagglutinin: I. Thymus dependence of antibody formation and thymus independence of immunological memory
CN112521511B (zh) 一种含EB病毒gB蛋白的自组装纳米颗粒及其制备方法与应用
JP2858848B2 (ja) B型肝炎ウイルスコア抗原粒子
JP2528815B2 (ja) 多効果免疫性蛋白質
Perham et al. Engineering a peptide epitope display system on filamentous bacteriophage
JP2002532387A (ja) ペプチドリガンドを介して結合された複数の免疫原性成分を有するhbvコア抗原粒子
JPH063445B2 (ja) 抗原活性アミノ酸連鎖の決定方法
CA2331846A1 (en) Expression vectors for stimulating an immune response and methods of using the same
JP2002520000A5 (cg-RX-API-DMAC7.html)
JP2003530123A (ja) B型肝炎コア抗原融合タンパク質
WO1984003506A1 (en) Antigenically active amino acid sequences
JPS63218627A (ja) ロタウイルスヌクレオキャプシドタンパクvp6のワクチン組成物への使用
CN1972710B (zh) 包含噬菌体纳米颗粒的方法和组合物
CA2331258A1 (en) Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220
Redmond et al. Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins
US20130295131A1 (en) Generation of antigenic virus-like particles through protein-protein linkages
WO1997020854A9 (en) Recombinant gas vesicles and uses thereof
WO1997020854A1 (en) Recombinant gas vesicles and uses thereof
CN121449698A (zh) 分子胶及纳米颗粒疫苗组合物
CN116271066A (zh) 一种重组腺病毒载体疫苗吸入给药递送系统
JP2002515249A5 (cg-RX-API-DMAC7.html)
CN118286410B (zh) 一种偶联CD8抗体的肿瘤mRNA疫苗的制备方法
CN117797252B (zh) 一种基于dna纳米技术的病毒多肽-蛋白亚单位组合疫苗及其制备方法和应用
Sjolander et al. Bacterial Expression Systems Based on a Protein A and Protein G Designed for the Production of Immunogens: Applications to Plasmodium falciparum Malaria Antigens
CN118576725A (zh) 一种以arc蛋白为载体的纳米颗粒及其制备方法和应用